CN111000537B - Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed - Google Patents

Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed Download PDF

Info

Publication number
CN111000537B
CN111000537B CN201911346488.2A CN201911346488A CN111000537B CN 111000537 B CN111000537 B CN 111000537B CN 201911346488 A CN201911346488 A CN 201911346488A CN 111000537 B CN111000537 B CN 111000537B
Authority
CN
China
Prior art keywords
blood pressure
age
pwv
sex
pulse wave
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911346488.2A
Other languages
Chinese (zh)
Other versions
CN111000537A (en
Inventor
陈妍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Affiliated Hospital of Army Medical University
Original Assignee
First Affiliated Hospital of Army Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Affiliated Hospital of Army Medical University filed Critical First Affiliated Hospital of Army Medical University
Priority to CN201911346488.2A priority Critical patent/CN111000537B/en
Publication of CN111000537A publication Critical patent/CN111000537A/en
Application granted granted Critical
Publication of CN111000537B publication Critical patent/CN111000537B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

The invention discloses a method for correcting the influence of age, sex and blood pressure on the pulse wave propagation speed, which is characterized by comprising the following steps: the method comprises the following steps: establishing a function family between PWV and blood pressure of a population without arteriosclerotic lesions, and obtaining function parameters corresponding to each age and gender to form a parameter database; establishing a normalized model of the PWV under the fixed age, gender and blood pressure states; obtaining corrections for PWV versus age, gender and blood pressure; the measured PWV is corrected with correction amounts for age, gender and blood pressure. Through the steps, the method can eliminate the influence of physiological factors such as age, sex, instant blood pressure and the like on the PWV, better reflect the change of the PWV caused by pathological factors such as hypertension, hyperlipidemia, diabetes, arteriosclerosis, end-stage nephropathy and the like, and enable the evaluation of arteriosclerosis to be more accurate.

Description

Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed
Technical Field
The invention relates to a method for correcting the influence of age, sex and blood pressure on the pulse wave propagation speed.
Background
Arteriosclerosis is a non-inflammatory lesion of an artery, mainly manifested by thickening of a blood vessel wall, deterioration of elasticity, narrowing of a lumen and plaque formation, and is an important prediction index of myocardial infarction and cerebral infarction. Conventional methods for diagnosing arteriosclerosis are classified into an imaging examination and a Pulse Wave Velocity (PWV) examination. The imaging examination includes methods such as arteriography, CT, doppler ultrasound, etc., mainly presumes the condition of the whole arterial system by observing the pathological changes of part of arteries, and is not suitable for large-area screening such as health examination, etc. in view of the problems of radiation, traumatism, operation difficulty, etc. The Pulse Wave Velocity (PWV) method is the most commonly used method in arteriosclerosis screening, has the advantages of simple and noninvasive measuring method, capability of quantitatively detecting the systemic arteriosclerosis degree and wide acceptance as an independent predictor of cardiovascular diseases.
The research on the PWV influence factors by Japan Qianye university and Cihui doctor, found that the factors clinically influencing PWV can be basically divided into physiological factors (such as sex, age, immediate blood pressure) and pathological factors (such as hypertension, hyperlipidemia, diabetes, arteriosclerosis, end-stage renal disease, etc.). Physiological factors are invariable factors, age is slowly-varying factors, and the influence of the physiological factors on the elasticity and toughness of the artery and the relation of the PWV have strong regularity and can be obtained by a statistical method. Blood pressure is a transient factor, and PWV is affected by blood pressure fluctuation caused by external stimuli (such as exercise, drugs, drinking, etc.). However, the change of PWV caused by physiological factors has a small correlation with the lesion of the artery wall, and is not suitable for detecting cardiovascular and cerebrovascular diseases. Currently there is no internationally recognized method or formula that can well rule out the effects of physiological factors, especially instantaneous blood pressure, on PWV. How to effectively eliminate the influence of gender, age and instant blood pressure so as to better extract the pathological change of PWV is an urgent problem to be solved.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a method for correcting the influence of age, sex and blood pressure on the pulse wave propagation speed, and the method can eliminate the influence of physiological factors such as age, sex and instant blood pressure on PWV and better reflect the pathological change of PWV.
A method of correcting the influence of age, sex and blood pressure on the pulse wave propagation velocity, characterized by: the method comprises the following steps:
s1) establishing a function family between PWV and blood pressure of the population without arteriosclerotic lesions, and obtaining function parameters corresponding to each age and sex to form a parameter database;
s2) establishing a normalized model of the PWV under the fixed age, gender and blood pressure states;
s3) obtaining correction amounts of PWV with respect to age, sex and blood pressure;
s4) corrects the measured PWV with correction amounts for age, sex, and blood pressure.
A functional family between PWV and blood pressure of the arteriosclerotic lesion-free population in step S1 is established using the following relationship:
Figure BDA0002333507220000021
wherein PWV is the pulse wave propagation velocity and BP is the blood pressure; i represents age, j represents gender; k is a radical ofijAnd bijIs a functional parameter related to gender and age.
K isijAnd bijObtained by the following method:
for each age and sex, a population without arteriosclerotic lesions (number of samples) was obtained>30) Blood pressure BP and PWV corresponding to it, which vary widely; obtaining a function parameter k corresponding to each age and gender by a curve fitting methodijAnd bijForming a database K of parametersijAnd Bij
Figure BDA0002333507220000022
Figure BDA0002333507220000023
Wherein, i is 1,2, …, n (1 is not less than n is not more than 100); j-M/F (M is male and F is female).
The method for obtaining the blood pressure BP with wide variation of the population without the arteriosclerotic lesion and the PWV corresponding to the blood pressure BP comprises the following steps:
selecting a crowd needing a surgical operation and without an arteriosclerotic focus as an acquisition object, and monitoring and recording arterial blood pressure in an operation anesthesia process in real time through arterial puncture;
meanwhile, collecting PWV corresponding to the arterial blood pressure time; PWV is obtained by detecting the pulse wave propagation time PTT and the propagation distance L, and by the following relationship:
Figure BDA0002333507220000031
in step S2, a normalized model of PWV at a fixed age, gender and blood pressure is established by:
selecting a function parameter k with age x and gender MxMAnd bxM(ii) a Selecting a blood pressure state BPx, calculating PWV at BPxxM:
Figure BDA0002333507220000032
In step S3, correction amounts of PWV with respect to age, sex, and blood pressure are obtained by normalizing the model:
in the blood pressure BPx state, the correction amount of PWV relative to age and sex is Δ PWV for the non-arteriosclerosis lesion group with age i and sex j relative to the non-arteriosclerosis lesion group with age x and sex M1
Figure BDA0002333507220000033
The actual blood pressure of a group without arteriosclerotic lesions of age i and sex j is BPm, and the correction amount of PWV relative to the selected blood pressure BPx is delta PWV2
Figure BDA0002333507220000034
In step S4, PWVm actually measured by the subject aged i and sexed j is corrected by the correction amount in step S3, and the corrected PWVr is:
Figure BDA0002333507220000035
the invention has the following beneficial effects:
the invention can eliminate the influence of physiological factors such as age, sex, instant blood pressure and the like on PWV, better reflect the change of PWV caused by pathological factors such as hypertension, hyperlipidemia, diabetes, arteriosclerosis, end-stage nephropathy and the like, and enable the evaluation of arteriosclerosis to be more accurate.
Drawings
FIG. 1 is a graph of sensitivity and specificity (ROC curve) of uncorrected PWVm for detecting atherosclerosis.
FIG. 2 is a graph of sensitivity and specificity (ROC curve) of PWVr in detecting atherosclerosis corrected by the method of the invention.
Detailed Description
The invention provides a method for correcting the influence of age, sex and blood pressure on the pulse wave propagation speed, which is characterized by comprising the following steps: the method comprises the following steps:
s1) establishing a function family between PWV and blood pressure of the population without arteriosclerotic lesions, and obtaining function parameters corresponding to each age and sex to form a parameter database;
establishing a family of functions requires establishing through the following relationships:
Figure BDA0002333507220000041
wherein PWV is the pulse wave propagation velocity and BP is the blood pressure; i represents age, j represents gender; k is a radical of formulaijAnd bijIs a functional parameter related to gender and age. Wherein k isijAnd bijThe acquisition of (2) requires obtaining a population without arteriosclerotic lesions (number of samples) for each age and sex>30) Blood pressure BP and PWV corresponding to it, which vary widely; obtaining a function parameter k corresponding to each age and gender by a curve fitting methodijAnd bijForming a database K of parametersijAnd Bij
Figure BDA0002333507220000042
Figure BDA0002333507220000043
Wherein, i is 1,2, …, n (1 is not less than n is not more than 100); j-M/F (M is male and F is female).
The method for obtaining the blood pressure BP widely varying in the population without the arteriosclerotic lesion and the PWV corresponding to the blood pressure BP comprises the following steps:
selecting a crowd needing a surgical operation and without an arteriosclerotic focus as a collection object, and monitoring and recording arterial blood pressure in an operation anesthesia process in real time through arterial puncture (under the multiple actions of an anesthetic, a vasoactive drug and an operation, the blood pressure in the operation fluctuates in a large range, and the change range can meet the requirement of curve fitting);
meanwhile, collecting PWV corresponding to the arterial blood pressure time; PWV is obtained by detecting the pulse wave propagation time PTT and the propagation distance L, and by the following relationship:
Figure BDA0002333507220000051
the means for detecting the pulse wave may include any one or more of the following: pressure sensors, photoplethysmography (PPG) or impedance plethysmography;
the method for obtaining the pulse wave propagation time PTT comprises the following steps: PTT can be obtained by simultaneous measurement of ECG, PPG, and ICG: firstly, obtaining the arrival time PAT of pulse propagation through ECG and PPG, wherein the PAT is defined as the time interval between the peak of an R wave of the ECG and the starting point of a PPG pulse wave signal; the pre-ejection PEP is then determined by ECG and ICG, PTT equals PAT minus PEP;
the PTT can also be obtained by synchronously detecting a PPG pulse wave signal at the proximal end and a PPG pulse wave signal at the distal end according to the time difference between the two pulse wave signals; the sites where the PPG signal is detected are preferably the ears and toes; specific identification methods for PTT can be understood by reference to YAN CHEN, CHANGYUN WEN, GUOCAI TAO, and MIN BI "Continuous and Noninival measurements of Systolic and Diastolic Blood Pressure by One film physical Model with the Same Model Parameters and Two Separate Pulse Wave sources 2012;
the pulse wave propagation distance L can be obtained by actual measurement, or can be estimated by subtracting a fixed constant from the percentage of the height or the height.
S2) establishing a normalized model of PWV at a fixed age, gender and blood pressure:
selecting a function parameter k with age x and gender MxMAnd bxM(ii) a Selecting a blood pressure state BPx, calculating PWV under BPxxM:
Figure BDA0002333507220000052
S3) obtaining correction amounts of PWV with respect to age, sex and blood pressure;
in the blood pressure BPx state, the correction amount of PWV relative to age and sex is Δ PWV for the non-arteriosclerosis lesion group with age i and sex j relative to the non-arteriosclerosis lesion group with age x and sex M1
Figure BDA0002333507220000061
The actual blood pressure of the patient without arteriosclerosis lesion is BPm, the age is i years, the sex is j, and the correction quantity of PWV is delta PWV relative to the selected blood pressure BPx2
Figure BDA0002333507220000062
S4) correcting the measured PWV with correction amounts for age, gender, and blood pressure:
PWVm actually measured by the subject aged i and sexed j is corrected by the correction amount in step S3, and the corrected PWVr is:
Figure BDA0002333507220000063
the method can eliminate the influence of age, sex and instant blood pressure and obtain the change of pulse wave propagation speed caused by pathological factors.
The above method is explained in detail by taking an example as follows:
this example shows how the method of the present invention can be used to correct PWV measured in a subject, to exclude the effects of age, sex, and blood pressure, and to obtain pathological changes in PWV.
The present embodiment employs an infrared photoplethysmography (PPG) to detect pulse wave signals of ears and toes of a subject to be measured, obtains a pulse wave propagation time PTT from a time difference between two pulse wave signals, and obtains PWV by the following relationship:
Figure BDA0002333507220000064
the propagation distance is determined by: l is-0.3 m in height.
Selecting a crowd needing a surgical operation and without an arteriosclerotic focus as an acquisition object, and monitoring and recording arterial blood pressure in an operation anesthesia process in real time through arterial puncture; and synchronously recording the PWV obtained by the method, and establishing a function family between the PWV of the population without the arteriosclerosis focus and the blood pressure and a function parameter database corresponding to each age and gender.
Figure BDA0002333507220000071
Figure BDA0002333507220000072
Then selecting a standard age, gender and pulse wave propagation distance L to establish a normalized model:
this embodiment selectsThe fixed age is 40 years old, and the gender is the mathematical model parameter of the male. In the above-mentioned established KijAnd BijK in the function parameter database for males aged 4040MAnd b40M11.2 and 255 respectively (as long as a function parameter database is established according to the steps provided by the invention, relevant specific numerical values can be obtained); the selected blood pressure state was the mean arterial pressure of 90 mmHg. The selected height is 1.7 m, and the pulse wave propagation distance L is 1.7-0.3-1.4 m. The normalized model of PWV is then:
Figure BDA0002333507220000073
the existing test subject with age of 60 years, sex of woman and height of 1.6 m (pulse wave propagation distance L is 1.6-0.3-1.3 m) has mathematical model parameter k60FAnd b60F12.7 and 242 respectively (may be at established K)ijAnd BijQueried in a function parameter database); when the actually measured mean arterial pressure is 102mmHg and the actually measured pulse wave propagation time PTT is 78 milliseconds, PWVm (m/s) is:
Figure BDA0002333507220000074
the corrected PWVr (m/s) is:
Figure BDA0002333507220000075
the 60 year old female received carotid ultrasound examination and the results showed: the carotid artery has normal vessel malformation, a thick intima-media, normal inner diameter of a vessel cavity and no abnormal echo in the vessel cavity, and obviously the subject does not have a typical arteriosclerosis focus. The actually measured PWvm is 16.67 m/s, which is obviously higher than that of normal people, reaches the standard of arteriosclerosis and is inconsistent with the result of ultrasonic imaging examination; however, the corrected PWVr was 12.72 m/s, which was not very different from the normal one, indicating that the subject did not develop significant arteriosclerosis, consistent with the results of the ultrasonography.
Fig. 1 and 2 show sensitivity and specificity curves (ROC curves) for uncorrected PWVm and PWVr corrected by the method of the invention for detecting atherosclerosis, respectively. Clearly, PWVr has higher specificity and sensitivity than PWVm (area 0.815vs 0.613 under ROC curve).
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.

Claims (5)

1. A method of correcting the influence of age, sex and blood pressure on the pulse wave propagation velocity, characterized by: the method comprises the following steps:
s1) establishing a function family between PWV and blood pressure of the population without arteriosclerotic lesions, and obtaining function parameters corresponding to each age and sex to form a parameter database;
s2) establishing a normalized model of the PWV under the fixed age, gender and blood pressure states;
s3) obtaining correction amounts of PWV with respect to age, sex and blood pressure;
s4) correcting the measured PWV with correction amounts for age, sex, and blood pressure;
a functional family between PWV and blood pressure of the arteriosclerotic lesion-free population in step S1 is established using the following relationship:
Figure FDA0003559193100000011
wherein PWV is the pulse wave propagation velocity and BP is the blood pressure; i representsAge, j represents gender; k is a radical ofijAnd bijIs a function parameter related to gender and age;
k is the same asijAnd bijObtained by the following method:
acquiring blood pressure BP and PWV corresponding to the blood pressure BP which are widely changed by people without arteriosclerotic lesions according to each age and sex; obtaining a function parameter k corresponding to each age and gender by a curve fitting methodijAnd bijForming a database K of parametersijAnd Bij
Figure FDA0003559193100000012
Figure FDA0003559193100000013
Wherein i is 1,2, …, n, 1 is less than or equal to n is less than or equal to 100; j is M/F, M is male, F is female.
2. The method of claim 1, wherein the influence of age, sex and blood pressure on the pulse wave velocity is corrected by: the method for obtaining the blood pressure BP with wide variation of the population without the arteriosclerotic focus and the corresponding PWV comprises the following steps:
selecting a crowd needing a surgical operation and without an arteriosclerotic focus as an acquisition object, and monitoring and recording arterial blood pressure in an operation anesthesia process in real time through arterial puncture;
meanwhile, collecting PWV corresponding to the arterial blood pressure time; PWV is obtained by detecting the pulse wave propagation time PTT and the propagation distance L, and by the following relationship:
Figure FDA0003559193100000021
3. the method of claim 1, wherein the influence of age, sex and blood pressure on the pulse wave velocity is corrected by:
in step S2, a normalized model of PWV at a fixed age, gender and blood pressure is established by:
selecting a function parameter k with age x and gender MxMAnd bxM(ii) a Selecting a blood pressure state BPx, calculating PWV under BPxxM:
Figure FDA0003559193100000022
4. A method for correcting the influence of age sex and blood pressure on the pulse wave propagation velocity according to claim 3, wherein:
in step S3, correction amounts of PWV with respect to age, sex, and blood pressure are obtained by normalizing the model:
in the blood pressure BPx state, the correction amount of PWV relative to age and sex is Δ PWV for the non-arteriosclerosis lesion group with age i and sex j relative to the non-arteriosclerosis lesion group with age x and sex M1
Figure FDA0003559193100000023
The actual blood pressure of the patient without arteriosclerosis lesion is BPm, the age is i years, the sex is j, and the correction quantity of PWV is delta PWV relative to the selected blood pressure BPx2
Figure FDA0003559193100000024
5. The method of claim 4, wherein the influence of age, sex and blood pressure on the pulse wave velocity is corrected by:
in step S4, the PWVm actually measured by the subject aged i and sexed j is corrected by the correction amount in step S3, and the corrected PWVr is:
Figure FDA0003559193100000031
CN201911346488.2A 2019-12-24 2019-12-24 Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed Active CN111000537B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911346488.2A CN111000537B (en) 2019-12-24 2019-12-24 Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911346488.2A CN111000537B (en) 2019-12-24 2019-12-24 Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed

Publications (2)

Publication Number Publication Date
CN111000537A CN111000537A (en) 2020-04-14
CN111000537B true CN111000537B (en) 2022-05-27

Family

ID=70116041

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911346488.2A Active CN111000537B (en) 2019-12-24 2019-12-24 Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed

Country Status (1)

Country Link
CN (1) CN111000537B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110251105B (en) * 2019-06-12 2022-06-21 广州视源电子科技股份有限公司 Noninvasive blood pressure measuring method, device, equipment and system
CN114176532B (en) * 2021-12-31 2023-06-23 北京大学人民医院 Clinical verification method for determining cfPWV parameters and application system thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017313A (en) * 1998-03-20 2000-01-25 Hypertension Diagnostics, Inc. Apparatus and method for blood pressure pulse waveform contour analysis
JP2000316821A (en) * 1999-05-06 2000-11-21 Nippon Colin Co Ltd Lower/upper extremity blood pressure index measuring apparatus
JP2001190506A (en) * 2000-01-17 2001-07-17 Nippon Colin Co Ltd Arterial sclerosis evaluating device
CN1593330A (en) * 2004-06-17 2005-03-16 肖行贯 Cardiovascular dynamics checking checkup method
EP1531732A2 (en) * 2002-06-05 2005-05-25 Wisconsin Alumni Research Foundation Ultrasonic apparatus and method for providing quantitative indication of risk of coronary heart disease
CN101229058A (en) * 2007-01-26 2008-07-30 香港中文大学 Initial calibrating equipment for using pulse wave transmitting time method to measure arteriotony
CN101810474A (en) * 2010-01-22 2010-08-25 徐亮禹 Device for realizing no-invasive measurement of blood pressure and pulse wave velocity
CN102397064A (en) * 2011-12-14 2012-04-04 中国航天员科研训练中心 Continuous blood pressure measuring device
CN205814309U (en) * 2016-04-29 2016-12-21 张苏豫 A kind of Intelligent alarm type blood pressure monitor system based on Internet of Things
CN107920763A (en) * 2015-07-16 2018-04-17 普瑞温迪克斯有限责任公司 Handle biological data
CN108523867A (en) * 2018-03-28 2018-09-14 武汉麦咚健康科技有限公司 A kind of self calibration PPG non-invasive blood pressure measuring methods and system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073392C (en) * 1997-08-27 2001-10-24 陈瑜 Multiple parameter monitor and its detecting method
JP3495348B2 (en) * 2001-07-02 2004-02-09 日本コーリン株式会社 Pulse wave velocity information measurement device
JP3530892B2 (en) * 2001-10-10 2004-05-24 コーリンメディカルテクノロジー株式会社 Vascular disorder diagnostic device
EP2074942B1 (en) * 2007-12-21 2012-02-01 CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement Method and apparatus for a continuous non-invasive and non-obstrusive monitoring of blood pressure
JP5644325B2 (en) * 2010-09-28 2014-12-24 オムロンヘルスケア株式会社 Blood pressure information measuring device and method for calculating an index of arteriosclerosis in the device
EP3220811B1 (en) * 2014-11-17 2023-10-18 David A. Borkholder Blood pressure and arterial compliance estimation from arterial segments
CN104958064A (en) * 2015-07-15 2015-10-07 四川宇峰科技发展有限公司 Wearable arteriosclerosis detector and pulse wave velocity detecting method
US20170119263A1 (en) * 2015-11-04 2017-05-04 Sharp Laboratories of America (SLA), Inc. System and Method for Deriving a Pulse Wave Velocity-Blood pressure Transform
US20170119265A1 (en) * 2015-11-04 2017-05-04 Sharp Laboratories of America (SLA), Inc. System and Method for using Demographic Data to Derive a Pulse Wave Velocity-Blood Pressure Transform
CN106618517B (en) * 2016-12-06 2020-12-08 山东大学 Method for evaluating artery elasticity function based on pulse wave of arm position change
CN107961001A (en) * 2017-12-20 2018-04-27 中国科学院深圳先进技术研究院 Appraisal procedure, device and the atherosclerosis detector of Degree of arteriosclerosis
CN108185996B (en) * 2017-12-27 2020-01-10 中国科学院深圳先进技术研究院 Arterial blood vessel age estimation model construction method and device

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017313A (en) * 1998-03-20 2000-01-25 Hypertension Diagnostics, Inc. Apparatus and method for blood pressure pulse waveform contour analysis
JP2000316821A (en) * 1999-05-06 2000-11-21 Nippon Colin Co Ltd Lower/upper extremity blood pressure index measuring apparatus
JP2001190506A (en) * 2000-01-17 2001-07-17 Nippon Colin Co Ltd Arterial sclerosis evaluating device
EP1531732A2 (en) * 2002-06-05 2005-05-25 Wisconsin Alumni Research Foundation Ultrasonic apparatus and method for providing quantitative indication of risk of coronary heart disease
CN1593330A (en) * 2004-06-17 2005-03-16 肖行贯 Cardiovascular dynamics checking checkup method
CN101229058A (en) * 2007-01-26 2008-07-30 香港中文大学 Initial calibrating equipment for using pulse wave transmitting time method to measure arteriotony
CN101810474A (en) * 2010-01-22 2010-08-25 徐亮禹 Device for realizing no-invasive measurement of blood pressure and pulse wave velocity
CN102397064A (en) * 2011-12-14 2012-04-04 中国航天员科研训练中心 Continuous blood pressure measuring device
CN107920763A (en) * 2015-07-16 2018-04-17 普瑞温迪克斯有限责任公司 Handle biological data
CN205814309U (en) * 2016-04-29 2016-12-21 张苏豫 A kind of Intelligent alarm type blood pressure monitor system based on Internet of Things
CN108523867A (en) * 2018-03-28 2018-09-14 武汉麦咚健康科技有限公司 A kind of self calibration PPG non-invasive blood pressure measuring methods and system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Evaluation of aortic flow alterations using MRI: Associations with left ventricular remodeling;Ioannis Bargiotas;《Computing in Cardiology 2014》;20150219;第21-24页 *
高血压病患者血压昼夜节律与性别、年龄关系的研究;彭万忠;《中国医药导刊》;20081231;第206-208 *

Also Published As

Publication number Publication date
CN111000537A (en) 2020-04-14

Similar Documents

Publication Publication Date Title
TWI669096B (en) Versatile monitoring device with a determining carotid artery pressure function
Laurent et al. Abridged version of the expert consensus document on arterial stiffness
Vermeersch et al. Determining carotid artery pressure from scaled diameter waveforms: comparison and validation of calibration techniques in 2026 subjects
Vappou et al. Non-invasive measurement of local pulse pressure by pulse wave-based ultrasound manometry (PWUM)
CN111000537B (en) Method for correcting influence of age, sex and blood pressure on pulse wave propagation speed
US20190246919A1 (en) Method and system for correcting pulse transit time associated with arterial blood pressure or blood pressure value calculated by pulse transit time
WO2012021765A2 (en) Methods and apparatus for determining arterial pulse wave velocity
Tang et al. Measurement of local pulse wave velocity for carotid artery by using an ultrasound-based method
US20070004982A1 (en) Apparatus and method for early detection of cardiovascular disease using vascular imaging
RU2511059C1 (en) Method for detecting high aortic rigidity in patients suffering cardiopathologies
Lee et al. Estimation of right atrial pressure on inferior vena cava ultrasound in Asian patients
JP5346555B2 (en) Ultrasound diagnostic device with arteriosclerosis risk display function
CN110960199B (en) System for double-variable measurement of arteriosclerosis degree
Mireles et al. A poor correlation exists between oscillometric and radial arterial blood pressure as measured by the Philips MP90 monitor
Sheaham et al. Observing the brachial artery through a pressure cuff
RU2327414C1 (en) Method of blood pressure measurement based on three-dimensional compression oscillogram
Graf et al. Non invasive assessment of carotid and femoral arterial pressure using B-mode ultrasound diameter waveforms
Lopez et al. Continuous blood pressure measurement in daily activities
Lee et al. Validation of a new index for estimating arterial stiffness: measurement of the QPV interval by Doppler ultrasound
Xu et al. Evaluation of Carotid Artery Blood Pressure Waveform Using a Wearable Ultrasound Patch
US20170367595A1 (en) Apparatus for measuring blood circulation disorders, and method therefor
Zanatta et al. COMPARATIVE ANALYSIS OF THE RESULTS IN ARTERIAL STIFFNESS BETWEEN TWO ASSESSMENT METHODS–SPHYGMOCOR AGAINST MOBIL-PULSE WAVE VELOCITY–IN HYPERTENSIVE PATIENTS
Xu et al. Continuous and Noninvasive Measurement of Arterial Pulse Pressure and Pressure Waveform using an Image-free Ultrasound System
Faita et al. P. 078 Validation of a New Automated Real-Time Measuring System for Carotid Intima—Media Thickness Assessment
Kreuz Vicorder Determined Aortic Pulse Wave Velocity (PWVa) Pulse Wave Analysis (PWA) Central Pressures

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant